论文部分内容阅读
先灵 -葆雅药厂的长效 α干扰素产品长效干扰素 α- 2 b已在英国和德国作为丙型肝炎治疗药首次投放市场 ,商品名分别为 Viraferon Peg和 Pag In-tron。特别标明为不能耐受利巴韦林及其禁忌证的丙型肝炎患者的单一疗法用药 ,已获得欧洲专利。这种长效制剂使干扰素躲避身体的免疫
Schering - a long-acting alpha-interferon product at Pau Pharmaceuticals The long-acting interferon alpha-2b has been first marketed as a Hepatitis C therapeutic in the UK and Germany under the trade names Viraferon Peg and Pag In-tron, respectively. Monotherapy for hepatitis C patients who are specifically marked as unable to tolerate ribavirin and its contraindications has been patented in Europe. This long-acting formulation keeps interferons from body immunity